EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine
Elham Barazeghi(Uppsala University), Peter Stålberg(Uppsala University Hospital), Gunnar Westin(Uppsala University Hospital), Per Hellman(Uppsala University Hospital), Olov Norlén(Uppsala University)
Cited by 23
Related Papers
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism
|Nature Genetics|2013|621
Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
|Circulation|2009|414